Phreesia, Inc. (NYSE:PHR – Get Free Report) COO Evan Roberts sold 12,749 shares of the company’s stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $27.31, for a total transaction of $348,175.19. Following the sale, the chief operating officer now owns 755,459 shares in the company, valued at $20,631,585.29. The trade was a 1.66 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.
Evan Roberts also recently made the following trade(s):
- On Wednesday, January 15th, Evan Roberts sold 1,785 shares of Phreesia stock. The stock was sold at an average price of $26.98, for a total value of $48,159.30.
- On Wednesday, January 8th, Evan Roberts sold 2,681 shares of Phreesia stock. The shares were sold at an average price of $27.95, for a total value of $74,933.95.
- On Monday, January 6th, Evan Roberts sold 2,873 shares of Phreesia stock. The shares were sold at an average price of $26.61, for a total value of $76,450.53.
Phreesia Stock Performance
Shares of PHR stock opened at $27.89 on Friday. The firm has a market capitalization of $1.62 billion, a price-to-earnings ratio of -18.98 and a beta of 0.94. The company has a 50 day moving average price of $24.00 and a 200 day moving average price of $23.00. Phreesia, Inc. has a one year low of $17.07 and a one year high of $29.16. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74.
Wall Street Analysts Forecast Growth
A number of equities analysts have commented on PHR shares. KeyCorp raised their target price on shares of Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 8th. JMP Securities reaffirmed a “market outperform” rating and issued a $30.00 price objective on shares of Phreesia in a research note on Tuesday, December 10th. Royal Bank of Canada raised shares of Phreesia from a “sector perform” rating to an “outperform” rating and upped their price target for the company from $24.00 to $32.00 in a report on Wednesday, January 8th. Needham & Company LLC reissued a “buy” rating and issued a $29.00 price target on shares of Phreesia in a report on Friday, January 10th. Finally, Citigroup boosted their target price on shares of Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a research note on Friday, January 10th. Twelve research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Phreesia has an average rating of “Buy” and a consensus target price of $31.00.
Check Out Our Latest Report on Phreesia
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the business. Champlain Investment Partners LLC raised its stake in shares of Phreesia by 4.1% in the 3rd quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company’s stock valued at $57,062,000 after acquiring an additional 97,847 shares during the period. Franklin Resources Inc. raised its position in Phreesia by 3.0% in the third quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company’s stock valued at $31,495,000 after purchasing an additional 42,973 shares during the period. State Street Corp lifted its stake in shares of Phreesia by 7.1% during the third quarter. State Street Corp now owns 1,327,586 shares of the company’s stock worth $30,256,000 after purchasing an additional 88,517 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of Phreesia by 4.7% in the third quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company’s stock valued at $28,397,000 after buying an additional 55,934 shares in the last quarter. Finally, TimesSquare Capital Management LLC grew its stake in shares of Phreesia by 2.3% in the third quarter. TimesSquare Capital Management LLC now owns 868,409 shares of the company’s stock valued at $19,791,000 after buying an additional 19,395 shares in the last quarter. 92.10% of the stock is owned by institutional investors and hedge funds.
About Phreesia
Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.
See Also
- Five stocks we like better than Phreesia
- Golden Cross Stocks: Pattern, Examples and Charts
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- How to Invest in Insurance Companies: A GuideĀ
- 3 Buy-and-Hold Stocks for Long-Term Growth
- Options Trading – Understanding Strike Price
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.